🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Improvement of Quality of Life (QoL) Using Preference-Oriented QoLMonitoring in Patients with Lung Cancer

RecruitingNAAges 18 Years - anyAllUniversity of Bayreuth
NCT06252233 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of the study is to determine whether a preference-oriented quality of life monitoring with defined diagnostic and therapeutic options improves quality of life in patients with lung cancer during routine follow-up care.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. primary diagnosis of lung cancer (ICD C33/C34, all stages) 2. treatment in one of six recruiting hospitals treating patients with lung cancer (University Hospital Regensburg, Hospital Barmherzige Brüder Regensburg, Hospital Bayreuth, Hospital Coburg, Hospital Kulmbach, Hospital Bamberg); 3. difference between date of histology and date of study entry not exceeding 2 months; 4. informed consent; Exclusion Criteria: 1. unavailability of a study clinician for patient recruitment; 2. patient misclassified in the candidate list (no primary diagnosis, no lung tumour); 3. coordinating practitioner refuses trial participation; 4. patient outside the defined study region (Germany, Bavaria: Upper Palatinate, Lower Bavaria, Upper Franconia); 5. age under 18 years; 6. pregnancy/ breastfeeding; 7. patient unable to fill out the QoL questionnaire (physical, psychological, cognitive, language reasons); 8. patient refuses trial participation
💊

What it tests

  • patient- and physician-centered QoL monitoring
  • Placebo
📍

Where

8 sites
Klinikum Bamberg
Bamberg, Germany
Hospital Bayreuth
Bayreuth, Germany
Klinikum Coburg GmbH
Coburg, Germany
Caritas Krankenhaus St. Maria Donaustauf
Donaustauf, Germany
Klinikum Kulmbach
Kulmbach, Germany
Krankenhaus Barmherzige Brüder
Regensburg, Germany
Universitätsklinikum Regensburg
Regensburg, Germany
Klinikum St. Elisabeth Straubing
Straubing, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy